Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler.

Next Previous
Trial Profile

Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms REALITY
  • Sponsors AstraZeneca

Most Recent Events

  • 27 Mar 2013 Treatment table added.
  • 21 Jan 2011 Actual end date changed from Aug 2006 to Sep 2006 as reported by ClinicalTrials.gov record.
  • 30 Dec 2008 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top